🇺🇸 FDA
Pipeline program

Lovaza, omega-3 fatty acid ethyl ester

M-10023

Phase 2 small_molecule active

Quick answer

Lovaza, omega-3 fatty acid ethyl ester for Mood Disorders is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Mood Disorders
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials